While cervical cancer is a serious disease that affects approximately 14,000 women each year, it is a disease that could be potentially eliminated due to effective...
Administration of Keytruda (pembrolizumab) in combination with chemotherapy improved overall survival in patients with previously untreated classical Hodgkin lymphoma (CHL), the study authors said. This is...
December 13, 2022 — Moderna and Merck jointly announced progress on Tuesday on a drug combination to combat recurrences of melanoma, a deadly form of skin...
Recent Comments